Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Inecalcitol

EU orphan designation number: EU/3/15/1523   
Active ingredient: Inecalcitol
Indication: Treatment of acute myeloid leukaemia
Sponsor: Hybrigenics SA
3-5 impasse Reille, 75014 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/07/2015 Orphan designation EMA/OD/045/15 (2015)5430 of 28/07/2015